Precision Oncology News: Lantern Pharma Preparing IND for Synthetic Lethality Program With FDA Feedback
January 18, 2023Jan 17, 2023 | staff reporter NEW YORK – Lantern Pharma on Tuesday said it received feedback from the US Food and Drug Administration that it will use to submit an investigational new drug application for LP-184. The company furthe …
Luiz Penalva, PhD to Receive Mike Hogg Fund Award
December 15, 2022Luiz O.F. Penalva, PhD to receive an award from the Mike Hogg Fund in support of his study, “Preventing Senescence Scape to Overcome Tumor Recurrence in Glioblastoma.” Learn more about Dr. Penalva’s research
Business Wire: Lantern Pharma to Host Virtual KOL Webinar on the Treatment of Pediatric Cancers During Childhood Cancer Awareness Month, featuring Peter Houghton, Ph.D.
September 20, 2022Webinar to be hosted on Thursday, Sept. 22, 2022, at 12:00 p.m. ET, register here. Dr. Houghton will discuss challenges in drug development for pediatric cancers and preliminary results from Lantern’s drug candidates in preclinical pediatric cancer mod …
Dr. Gupta to Present at American Society for Biochemistry & Molecular Biology 10/1
September 19, 2022Talk Title: Structured RNAs restrict the N6-adenine methylation (m6dA) activity of human METTL3-METTL14
Congratulations, Dr. Henry Miller!
September 19, 2022Good afternoon, everyone! Please join us and Dr. Alexander J.R. Bishop in congratulating Henry Miller on his passing his PhD Defense with honors! Way to go Henry!!!!! _________________________________________________________ Since 2004, UT Health San A …
UT Health SA Newsroom: CPRIT awards $8 million for Greehey Children’s Cancer Research Institute core labs
September 15, 2022UT Health SA Newsroom: The University of Texas Health Science Center at San Antonio moves up in Forbes Best-In-State Employers list
August 31, 2022Posted on August 29, 2022 at 10:39 am. Shared by Steven Lee Now ranked 12th; fifth among health care/social employers. The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has jumped to 12th on Forbes magazine’s list of …
Dr. Zhao Lai to Receive NCI R50 Funding
August 24, 2022The National Cancer Institute (NCI) has recently awarded an R50 Research Specialist Award to Dr. Zhao Lai, Associate Professor/Research, Director of the Next-Generation Sequencing Shared Resource (NGSSR) in the NCI-designated Mays Cancer Center (MCC). …
Business Wire: Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights, Scientific Collaborations Updates (Houghton)
August 9, 2022During Childhood Cancer Awareness Month in September, Lantern will host a KOL webinar featuring Dr. Peter Houghton, Ph.D., a leading expert in childhood cancers at the Greehey Children’s Cancer Institute at the University of Texas San Antonio Health Sc …
Dr. Raushan Kurmasheva Received the CURE Childhood Cancer Award
June 24, 2022Abstract Atypical teratoid/rhabdoid tumors (AT/RT) of the brain and malignant rhabdoid tumors of the kidney (RTK) compose a group of highly malignant pediatric cancers known as malignant rhabdoid tumors (MRT). Both subtypes are characterized by the bia …